
Opinion|Videos|October 21, 2024
Final Thoughts on Dravet Syndrome Management
Author(s)M. Scott Perry, MD
Key Takeaways
- Early diagnosis in Dravet syndrome is critical to prevent developmental delays and cognitive impairments, enhancing long-term outcomes.
- Achieving seizure freedom is a primary goal, utilizing antiepileptic drugs, dietary therapies, and novel treatments like cannabidiol and fenfluramine.
Scott Perry, MD, discusses how effective management of Dravet syndrome requires a multidisciplinary approach, emphasizing the critical importance of early diagnosis and aggressive treatment aimed at achieving seizure freedom, which can significantly improve long-term outcomes and quality of life for patients.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Can you provide any takeaway messages on the management of Dravet syndrome for your fellow HCPs?
- Please also touch on the importance of early diagnosis and seizure freedom.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
3
Using Human iPSC Models to Dissect PIRA Mechanisms in Progressive Multiple Sclerosis: Valentina Fossati, PhD
4
Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib
5











